Hca Healthcare, Inc. HCA
Revenue Intelligence Report • 36 quarters of SEC filing data • Updated 2026-03-15
Hca Healthcare, Inc. has a forecasted full-year revenue of $83B, a +10.2% year-over-year change, based on 36 quarters of SEC filing data. Key revenue drivers include SG&A ($63.49 per $1). The ARDL model achieves strong accuracy at 2.4% MAPE.
Investment Thesis
Our ARDL model tracks Hca Healthcare, Inc.'s revenue with exceptional precision (2.4% MAPE), indicating highly predictable cash flows. Each $1 of SG&A spending generates $63.49 in revenue, reflecting strong commercial efficiency.
Next FY Revenue
$83.3B
+10.2% YoY
SG&A Multiplier
$63.49 per $1
Model Accuracy
2.4% MAPE
Holdout validation: The model predicted $20B vs the actual $20B — an error of 0.6%.
Note:
Hca Healthcare, Inc. does not report R&D expenses separately. This analysis uses SG&A spending only.
Revenue Forecast
Quarterly Detail
| Quarter | Model Forecast | Actual | 95% Range | YoY Growth | Status |
|---|---|---|---|---|---|
| Q4 2025 | $20B | $20B | $19B – $21B | +7.3% | ✓ In range |
| Q2 2026 | $20B | $19B – $21B | +9.5% | ||
| Q3 2026 | $21B | $19B – $22B | +10.4% | ||
| Q4 2026 | $21B | $19B – $23B | +10.1% | ||
| Q1 2027 | $22B | $20B – $24B | +10.9% |
How Spending Drives Revenue
Reading this chart:
Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch